Meta-analysis of 52 studies (91,913 men with prostate cancer): pooled prevalence of osteoporosis was 22.0% and of low bone mass 41.7%, with very high heterogeneity. No significant link with ADT duration (data from only 24 studies), which does not rule one out.
Meta-analysisn = 91,913
Ebrahimi et al. Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis